You cannot establish that NAD+ therapy is working from an immediate sensation or a symptom diary alone. Track changes in energy, sleep, and daily functioning with your physician, while recognizing that clinical evidence for intravenous NAD+ in wellness remains inconclusive and there is no established number of sessions that guarantees benefit.
TL;DR
- Knowing whether NAD+ therapy is working requires clinical review; symptom improvement alone does not establish treatment effectiveness.
- Tell the supervising clinician immediately about chest pressure, breathing difficulty, or any new or worsening infusion symptoms.
- No validated 48–72-hour response window or three-to-four-session rule establishes that NAD+ infusions work.
- Infusion Center of NJ provides physician-led assessment; treatment decisions should reflect evidence limits, risks, and individual goals.
Why this matters
NAD+ is involved in cellular metabolism. Its biological role does not, by itself, establish that an intravenous infusion improves fatigue, cognition, sleep, or aging-related outcomes.
A 2026 systematic review of NAD+ supplementation included 33 human intervention studies and found no eligible clinical-outcome trials of intravenous or intramuscular NAD+ itself for anti-aging or wellness indications. Its search covered January 2010 through October 2025. Findings about oral precursors, animal experiments, or changes in blood markers should not be presented as proof that NAD+ infusions improve how patients feel or function.
At Infusion Center of NJ, NAD+ therapy is offered in a physician-led setting in Clifton and Tenafly. A consultation is an opportunity to discuss what is known, what remains uncertain, and whether an infusion is appropriate for your circumstances—not a promise of a particular result.
How can you tell if NAD+ therapy is working for you?
A diary can document your experience, but it cannot separate a treatment effect from changes in sleep, stress, other care, expectations, or the natural course of symptoms. Use a symptom log to support a physician discussion, not to prove efficacy or justify more infusions.
Before treatment, agree on the specific concern being assessed and how you will review it. Persistent fatigue, cognitive changes, or sleep problems deserve medical evaluation rather than an assumption that they reflect a need for NAD+.
What you'll need
- A description of the symptoms or goals you want to discuss.
- Your medication and supplement list and relevant medical history.
- A simple diary that records symptoms alongside sleep, activity, stress, and other changes.
- A plan for reporting side effects and reviewing whether treatment should continue.
The steps
1. Record your baseline before treatment
Write down what your symptoms prevent you from doing and how often they occur. If useful, use the same personal rating scale each day; a number helps you describe your experience but is not a validated test of NAD+ effectiveness.
Include what else is happening. A change in medication, a better night's sleep, or an illness can affect your scores independently of an infusion.
2. Report symptoms during the infusion immediately
Tell the supervising clinician immediately about chest pressure, chest pain, breathing difficulty, or any new or worsening symptoms during an infusion. Do not assume these symptoms are harmless or continue without assessment.
Report nausea, flushing, headache, chills, shaking, vomiting, or unusual fatigue as well. Do not wait until a later visit or adjust the infusion yourself. The treating clinician should assess symptoms and decide whether treatment must be stopped or changed.
For chest pain, severe breathing difficulty, fainting, or another potentially life-threatening symptom after leaving the clinic, call 911. Do not use a symptom diary or a routine follow-up appointment in place of emergency assessment.
3. Track changes without expecting a fixed response window
Record how you feel after treatment and over the follow-up period agreed with your physician. There is no established 48–72-hour window in which improvement proves that an NAD+ infusion is working.
Document lack of change and worsening symptoms as carefully as improvement. Feeling nothing is not evidence that you need a higher dose or additional visits.
4. Compare daily functioning, not just a single good day
Bring concrete examples to the review: whether a usual task became easier, whether a symptom persisted, and what else changed. Improvement is worth discussing, but a before-and-after comparison without a control cannot establish what caused it.
Do not treat a strong sensation during the infusion as a sign of greater benefit. An adverse reaction is a safety concern, not a measure of treatment success.
5. Avoid a preset series as a test of effectiveness
There is no validated rule that three or four NAD+ infusions establish benefit for wellness. Do not book a course simply because an earlier session produced no noticeable effect.
Ask your physician to explain the rationale for any proposed schedule, the uncertainties, and the criteria for stopping. Continuing treatment should be a considered decision, not a way to chase a promised timeline.
6. Review whether to stop, reconsider, or seek another assessment
A sustained change, no change, or a worsening pattern should all prompt a discussion of the next step. A plateau does not prove that you have reached a beneficial maintenance level, and symptoms returning do not prove that another infusion is needed.
Infusion Center of NJ can discuss your experience alongside your medical history. Ask whether other explanations for your symptoms need investigation and what alternatives are appropriate.
Discuss your NAD+ experience
Talk with a physician in Clifton or Tenafly about your symptoms, treatment goals, risks, and the limits of current evidence.
Troubleshooting
I felt nothing after my first session. Do not assume that a longer series will produce a result. Review whether continuing has a reasonable clinical rationale before booking more treatment.
I felt worse during or after the infusion. Report symptoms promptly. Do not dismiss them as detoxification, an expected adjustment, or something that must resolve within an hour.
I felt better for a while, then symptoms returned. A return of symptoms does not establish that the treatment wore off or that the interval should be shortened. Discuss alternative explanations and reassessment.
I cannot tell whether a change came from NAD+. A diary helps explain your experience, but uncertainty can remain even with careful records. It is appropriate to discuss stopping rather than continuing indefinitely without clear benefit.
Product quality is part of the safety discussion
In an October 30, 2024 safety notice, FDA warned about food-grade NAD+ being used to compound intravenous products without appropriate processing. FDA described reports of severe chills, shaking, vomiting, and fatigue, with some patients requiring medical treatment; those reactions were consistent with excessive endotoxin exposure.
This notice concerns ingredient suitability and sterile preparation. It does not establish that Infusion Center of NJ used an affected product. Ask the treating practice about pharmacy sourcing and how product-quality concerns are addressed; physician supervision does not eliminate all treatment risks.
What to do next
Bring your symptom record, medication list, and questions to a physician discussion before deciding on further infusions. Ask what outcome would justify continuing, what would lead to stopping, and whether your symptoms need a different evaluation.
This article provides general information, not an individualized diagnosis, dosing plan, or treatment recommendation.
FAQ
How can I know if NAD+ therapy is working?
Discuss changes in symptoms and daily functioning with your physician. A diary can document your experience, but improvement alone cannot establish that an NAD+ infusion caused it.
How long does it take to feel NAD+ effects?
There is no established response window that proves effectiveness for intravenous NAD+ in wellness. A 2026 systematic review found no eligible clinical-outcome trials of IV NAD+ itself for these indications.
Does feeling nothing mean I need more NAD+ sessions?
No. Lack of an effect is not a reason on its own to increase the dose or book more sessions; review the rationale and alternatives with your physician.
What should I do about chest pressure during an NAD+ infusion?
Tell the supervising clinician immediately and do not continue without assessment. Chest pain, severe breathing difficulty, fainting, or another potentially life-threatening symptom after leaving the clinic requires emergency help; call 911.
How many NAD+ sessions are needed to judge results?
There is no validated three-to-four-session rule for wellness benefits. Agree on review and stopping criteria with your physician rather than relying on a guaranteed course length.
Does a return of fatigue mean I need a maintenance infusion?
No. Symptoms returning can have other explanations and should prompt reassessment rather than an automatic shorter interval between infusions.
What should I track before starting NAD+ therapy?
Record the symptoms you want evaluated, their effect on daily activities, and relevant sleep, stress, medication, or health changes. Use the record to support a medical discussion, not as proof of treatment effectiveness.
Is combining NAD+ with other IV treatments safer or more effective?
Do not assume a combination is safer or more effective. Each ingredient adds its own considerations, and any proposed combination requires an individualized discussion of evidence and risks.
One last thing
A symptom log is a communication tool, not a reason to keep buying treatment. In 2026, the responsible question is not how many NAD+ sessions you should complete, but whether the evidence, your health assessment, and your experience justify continuing.